Subclinical target organ damage in subjects with different components of metabolic syndrome

Background: To assess the association of metabolic syndrome (MS) and its components with target organ damage in a follow-up study of relatively healthy bank employers. Methods: Out of 1600 random samples of office workers in Saint Petersburg (Russia), a group of 383 participants with at least one co...

Full description

Bibliographic Details
Main Authors: Oxana P. Rotar, Maria A. Boyarinova, Ekaterina V. Moguchaia, Ekaterina P. Kolesova, Anastasya M. Erina, Vladislav N. Solntsev, Alexandra O. Konradi, Eugene V. Shlyakhto
Format: Article
Language:English
Published: Taylor & Francis Group 2018-07-01
Series:Clinical and Experimental Hypertension
Subjects:
Online Access:http://dx.doi.org/10.1080/10641963.2017.1384488
_version_ 1797681347104342016
author Oxana P. Rotar
Maria A. Boyarinova
Ekaterina V. Moguchaia
Ekaterina P. Kolesova
Anastasya M. Erina
Vladislav N. Solntsev
Alexandra O. Konradi
Eugene V. Shlyakhto
author_facet Oxana P. Rotar
Maria A. Boyarinova
Ekaterina V. Moguchaia
Ekaterina P. Kolesova
Anastasya M. Erina
Vladislav N. Solntsev
Alexandra O. Konradi
Eugene V. Shlyakhto
author_sort Oxana P. Rotar
collection DOAJ
description Background: To assess the association of metabolic syndrome (MS) and its components with target organ damage in a follow-up study of relatively healthy bank employers. Methods: Out of 1600 random samples of office workers in Saint Petersburg (Russia), a group of 383 participants with at least one component of MS and without cardiovascular complications was selected (mean age 46.6 ± 9.0 years, 214 females (64.6%)). Follow-up visit was performed in 331 subjects. Target organ damage (TOD) was assessed by echocardiography, carotid ultrasound, applanational tonometry, brachial–ankle index, and urine albumin excretion measurements. Anthropometry, vital signs, and biochemistry were performed according to standard protocols. Results: Presence of MS was not associated with higher probability of TOD. Multiple linear regression revealed significant association of all markers of TOD with older age. Hypertension was a significant predictor of left ventricular hypertrophy (LVH), increased arterial stiffness, and early signs of carotid atherosclerosis in logistic regression adjusted for age and gender. During follow-up, proportion of patients with LVH significantly decreased (from 46.7% to 32.9%, р = 0.003) and prevalence of patients with IMT > 0.09 сm increased (from 24.5% to 44.1%, p < 0.001) accompanying by significant declining of office blood pressure (BP) and total cholesterol. Conclusions: MS per se is not related to increased probability to TOD. Hypertension, female gender, and older age are main determinants of subclinical changes. After 2-years follow-up, significant LVH and renal damage regression was observed probably owing to BP reduction. Alternatively, early signs of carotid atherosclerosis increase with aging despite decreasing of the prevalence of hypercholesterolemia.
first_indexed 2024-03-11T23:43:34Z
format Article
id doaj.art-0209db8c16a146d38f11152be10a6b9d
institution Directory Open Access Journal
issn 1064-1963
1525-6006
language English
last_indexed 2024-03-11T23:43:34Z
publishDate 2018-07-01
publisher Taylor & Francis Group
record_format Article
series Clinical and Experimental Hypertension
spelling doaj.art-0209db8c16a146d38f11152be10a6b9d2023-09-19T15:19:26ZengTaylor & Francis GroupClinical and Experimental Hypertension1064-19631525-60062018-07-0140542142610.1080/10641963.2017.13844881384488Subclinical target organ damage in subjects with different components of metabolic syndromeOxana P. Rotar0Maria A. Boyarinova1Ekaterina V. Moguchaia2Ekaterina P. Kolesova3Anastasya M. Erina4Vladislav N. Solntsev5Alexandra O. Konradi6Eugene V. Shlyakhto7Almazov National Medical Research CentreAlmazov National Medical Research CentreAlmazov National Medical Research CentreAlmazov National Medical Research CentreAlmazov National Medical Research CentreAlmazov National Medical Research CentreAlmazov National Medical Research CentreAlmazov National Medical Research CentreBackground: To assess the association of metabolic syndrome (MS) and its components with target organ damage in a follow-up study of relatively healthy bank employers. Methods: Out of 1600 random samples of office workers in Saint Petersburg (Russia), a group of 383 participants with at least one component of MS and without cardiovascular complications was selected (mean age 46.6 ± 9.0 years, 214 females (64.6%)). Follow-up visit was performed in 331 subjects. Target organ damage (TOD) was assessed by echocardiography, carotid ultrasound, applanational tonometry, brachial–ankle index, and urine albumin excretion measurements. Anthropometry, vital signs, and biochemistry were performed according to standard protocols. Results: Presence of MS was not associated with higher probability of TOD. Multiple linear regression revealed significant association of all markers of TOD with older age. Hypertension was a significant predictor of left ventricular hypertrophy (LVH), increased arterial stiffness, and early signs of carotid atherosclerosis in logistic regression adjusted for age and gender. During follow-up, proportion of patients with LVH significantly decreased (from 46.7% to 32.9%, р = 0.003) and prevalence of patients with IMT > 0.09 сm increased (from 24.5% to 44.1%, p < 0.001) accompanying by significant declining of office blood pressure (BP) and total cholesterol. Conclusions: MS per se is not related to increased probability to TOD. Hypertension, female gender, and older age are main determinants of subclinical changes. After 2-years follow-up, significant LVH and renal damage regression was observed probably owing to BP reduction. Alternatively, early signs of carotid atherosclerosis increase with aging despite decreasing of the prevalence of hypercholesterolemia.http://dx.doi.org/10.1080/10641963.2017.1384488carotid atherosclerosishypertensionleft ventricular damagemetabolic syndrometarget organ damage
spellingShingle Oxana P. Rotar
Maria A. Boyarinova
Ekaterina V. Moguchaia
Ekaterina P. Kolesova
Anastasya M. Erina
Vladislav N. Solntsev
Alexandra O. Konradi
Eugene V. Shlyakhto
Subclinical target organ damage in subjects with different components of metabolic syndrome
Clinical and Experimental Hypertension
carotid atherosclerosis
hypertension
left ventricular damage
metabolic syndrome
target organ damage
title Subclinical target organ damage in subjects with different components of metabolic syndrome
title_full Subclinical target organ damage in subjects with different components of metabolic syndrome
title_fullStr Subclinical target organ damage in subjects with different components of metabolic syndrome
title_full_unstemmed Subclinical target organ damage in subjects with different components of metabolic syndrome
title_short Subclinical target organ damage in subjects with different components of metabolic syndrome
title_sort subclinical target organ damage in subjects with different components of metabolic syndrome
topic carotid atherosclerosis
hypertension
left ventricular damage
metabolic syndrome
target organ damage
url http://dx.doi.org/10.1080/10641963.2017.1384488
work_keys_str_mv AT oxanaprotar subclinicaltargetorgandamageinsubjectswithdifferentcomponentsofmetabolicsyndrome
AT mariaaboyarinova subclinicaltargetorgandamageinsubjectswithdifferentcomponentsofmetabolicsyndrome
AT ekaterinavmoguchaia subclinicaltargetorgandamageinsubjectswithdifferentcomponentsofmetabolicsyndrome
AT ekaterinapkolesova subclinicaltargetorgandamageinsubjectswithdifferentcomponentsofmetabolicsyndrome
AT anastasyamerina subclinicaltargetorgandamageinsubjectswithdifferentcomponentsofmetabolicsyndrome
AT vladislavnsolntsev subclinicaltargetorgandamageinsubjectswithdifferentcomponentsofmetabolicsyndrome
AT alexandraokonradi subclinicaltargetorgandamageinsubjectswithdifferentcomponentsofmetabolicsyndrome
AT eugenevshlyakhto subclinicaltargetorgandamageinsubjectswithdifferentcomponentsofmetabolicsyndrome